INVENTRONICS LTD (IVX.CA) Stock Fundamental Analysis
Canada - TSX-V:IVX - CA4612082095 - Common Stock
0.79 CAD
+0.04 (+5.33%)
Overall IVX gets a fundamental rating of 5 out of 10. We evaluated IVX against 3 industry peers in the Building Products industry. While IVX has a great health rating, its profitability is only average at the moment. IVX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year IVX was profitable.
IVX had a positive operating cash flow in the past year.
Of the past 5 years IVX 4 years were profitable.
Each year in the past 5 years IVX had a positive operating cash flow.
1.2 Ratios
IVX has a Return On Assets of 1.84%. This is in the lower half of the industry: IVX underperforms 66.67% of its industry peers.
IVX has a Return On Equity of 4.61%. This is in the lower half of the industry: IVX underperforms 66.67% of its industry peers.
IVX's Return On Invested Capital of 3.94% is amongst the best of the industry. IVX outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IVX is significantly above the industry average of 3.94%.
The 3 year average ROIC (16.93%) for IVX is well above the current ROIC(3.94%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 4.61% | ||
| ROIC | 3.94% |
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
1.3 Margins
With a Profit Margin value of 1.55%, IVX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Looking at the Operating Margin, with a value of 3.92%, IVX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of IVX has declined.
Looking at the Gross Margin, with a value of 17.94%, IVX is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of IVX has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.92% | ||
| PM (TTM) | 1.55% | ||
| GM | 17.94% |
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IVX is creating value.
IVX has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for IVX has been increased compared to 5 years ago.
The debt/assets ratio for IVX has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.46 indicates that IVX is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.46, IVX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
IVX has a debt to FCF ratio of 4.28. This is a neutral value as IVX would need 4.28 years to pay back of all of its debts.
IVX's Debt to FCF ratio of 4.28 is amongst the best of the industry. IVX outperforms 100.00% of its industry peers.
IVX has a Debt/Equity ratio of 0.90. This is a neutral value indicating IVX is somewhat dependend on debt financing.
The Debt to Equity ratio of IVX (0.90) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | 2.46 |
ROIC/WACC0.43
WACC9.1%
2.3 Liquidity
IVX has a Current Ratio of 2.34. This indicates that IVX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.34, IVX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
IVX has a Quick Ratio of 1.54. This is a normal value and indicates that IVX is financially healthy and should not expect problems in meeting its short term obligations.
IVX has a better Quick ratio (1.54) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.34 | ||
| Quick Ratio | 1.54 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 113.76% over the past year.
IVX shows a small growth in Revenue. In the last year, the Revenue has grown by 4.99%.
IVX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.21% yearly.
EPS 1Y (TTM)113.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2250%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%69.48%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
IVX is valuated quite expensively with a Price/Earnings ratio of 39.50.
66.67% of the companies in the same industry are more expensive than IVX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.27. IVX is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IVX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IVX indicates a rather cheap valuation: IVX is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.88 | ||
| EV/EBITDA | 11.9 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
IVX has a Yearly Dividend Yield of 23.33%, which is a nice return.
IVX's Dividend Yield is rather good when compared to the industry average which is at 23.33. IVX pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, IVX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 23.33% |
5.2 History
IVX has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
430.97% of the earnings are spent on dividend by IVX. This is not a sustainable payout ratio.
DP430.97%
EPS Next 2YN/A
EPS Next 3YN/A
TSX-V:IVX (9/15/2025, 7:00:00 PM)
0.79
+0.04 (+5.33%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.93%
Ins Owner ChangeN/A
Market Cap3.85M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 23.33% |
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP430.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.5 | ||
| Fwd PE | N/A | ||
| P/S | 0.53 | ||
| P/FCF | 6.88 | ||
| P/OCF | 5.26 | ||
| P/B | 1.57 | ||
| P/tB | 1.57 | ||
| EV/EBITDA | 11.9 |
EPS(TTM)0.02
EY2.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY14.53%
OCF(TTM)0.15
OCFY19.03%
SpS1.5
BVpS0.5
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 4.61% | ||
| ROCE | 5.84% | ||
| ROIC | 3.94% | ||
| ROICexc | 4.34% | ||
| ROICexgc | 4.34% | ||
| OM | 3.92% | ||
| PM (TTM) | 1.55% | ||
| GM | 17.94% | ||
| FCFM | 7.65% |
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
ROICexc(3y)18.71%
ROICexc(5y)18%
ROICexgc(3y)18.71%
ROICexgc(5y)18%
ROCE(3y)25.1%
ROCE(5y)24.63%
ROICexcg growth 3Y-68.88%
ROICexcg growth 5Y-39.12%
ROICexc growth 3Y-68.88%
ROICexc growth 5Y-39.12%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
F-Score7
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 4.53 | ||
| Cap/Depr | 86.5% | ||
| Cap/Sales | 2.37% | ||
| Interest Coverage | 1.99 | ||
| Cash Conversion | 150.62% | ||
| Profit Quality | 494.69% | ||
| Current Ratio | 2.34 | ||
| Quick Ratio | 1.54 | ||
| Altman-Z | 2.46 |
F-Score7
WACC9.1%
ROIC/WACC0.43
Cap/Depr(3y)281.39%
Cap/Depr(5y)239.45%
Cap/Sales(3y)5.39%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)113.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2250%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%69.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.55%
EBIT growth 3Y-69.33%
EBIT growth 5Y-34.39%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.84%
FCF growth 3Y-16.33%
FCF growth 5Y11.05%
OCF growth 1Y-74.33%
OCF growth 3Y-11.65%
OCF growth 5Y14.04%